Breast Cancer Update cover art

Breast Cancer Update

Breast Cancer Update

By: Dr. Neil Love
Listen for free

About this listen

 Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.Copyright 2025 Research To Practice. All Rights Reserved Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management

    Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management
    Jul 29 2025

    Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, discusses the efficacy and safety of approved and investigational antibody-drug conjugates for endocrine-resistant HR-positive and triple-negative metastatic breast cancer.

    CME information and select publications here.

    Show More Show Less
    28 mins
  • Metastatic Breast Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

    Metastatic Breast Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
    Jul 4 2025

    Dr Harold Burstein, Dr Javier Cortés, Prof Rebecca A Dent, Dr Kevin Kalinsky, Dr Joyce O’Shaughnessy and moderator Dr Hope S Rugo present data informing treatment decision-making for patients with metastatic breast cancer at the 2025 ASCO annual meeting.

    CME information and select publications here.

    Show More Show Less
    1 hr and 58 mins
  • IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies

    IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies
    Jun 23 2025

    Dr Patrick Wen from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses the current and future management of IDH-mutant gliomas.

    CME information and select publications here.

    Show More Show Less
    54 mins
No reviews yet